GL Pharm Tech Corp. | Income Statement
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
3,766
7,194
6,475
4,636
2,414
Cost of Goods Sold (COGS) incl. D&A
2,130
5,295
3,572
4,853
3,853
Gross Income
1,636
1,899
2,903
217
1,439
SG&A Expense
1,496
1,617
1,948
2,539
2,802
EBIT
136
282
-
2,765
4,248
Unusual Expense
67
-
52
40
28
Non Operating Income/Expense
34
99
20
2,602
36
Interest Expense
61
56
73
76
103
Pretax Income
175
196
894
5,275
4,237
Consolidated Net Income
175
196
1,084
5,494
4,237
Net Income
175
196
1,084
5,494
4,237
Net Income After Extraordinaries
175
196
1,084
5,494
4,237
Net Income Available to Common
175
196
1,084
5,494
4,237
EPS (Basic)
953.27
1,066.04
50.00
193.00
138.00
Basic Shares Outstanding
-
-
21
28
31
EPS (Diluted)
953.27
1,066.04
45.18
192.91
137.72
Diluted Shares Outstanding
-
-
24
28
31
EBITDA
336
439
1,134
2,490
3,847
Other Operating Expense
4
-
17
8
7
Non-Operating Interest Income
68
69
48
128
135
Equity in Affiliates (Pretax)
-
-
-
-
29
About GL Pharm Tech
View Profile
